ArticleAsian Pacific journal of cancer prevention : APJCP2026
A Cost-Effectiveness Analysis of Tobacco Generational Endgame Scenarios in Malaysia: A Comparison of a Total Ban versus Smokeless-Only Policies.
Article in Asian Pacific journal of cancer prevention : APJCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe use of tobacco products is associated with the treatment costs of lung-related diseases. The Tobacco Generational Endgame (GEG) strategy can improve efficiency in managing medical costs.
methodsThree GEG scenarios were identified. In Scenario 1, the GEG policy was not implemented. Scenario 2 prohibited the use of all tobacco products. Scenario 3 allowed only smokeless tobacco products. Secondary data obtained from the Ministry of Health (MOH) Malaysia were analysed using the Incremental Cost-Effectiveness Ratio (ICER) and sensitivity analysis.
resultsIn 2019, the Ministry of Health (MOH) spent MYR 71,527,032.50 on the treatment of chronic obstructive pulmonary disease and MYR 38,112,229.30 on lung cancer. The estimated annual cost for the Tobacco Control Programme was MYR 142,389,194.40. Analysis shows that Scenario 3 is the most cost-effective.
conclusionsThe results of this study can serve as a guide for the government in formulating policies that maximise the benefits of GEG implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.